Fluzone^® Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adults

References

• Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA289, 179–186 (2003).
   PubMed Web of Science ®Google Scholar
• Monto AS, Ansaldi F, Aspinall R et al. Influenza control in the 21st century: optimizing protection of older adults. Vaccine27(37), 5043–5053 (2009).
   PubMed Web of Science ®Google Scholar
• Dao CN, Kamimoto L, Nowell M et al. Adult hospitalizations for laboratory-positive influenza during the 2005–2006 through 2007–2008 seasons in the United States. J. Infect. Dis.202, 881–888 (2010).
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E et al. Influenza-associated hospitalizations in the United States. JAMA292, 1333–1340 (2004).
   PubMed Web of Science ®Google Scholar
• Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine24, 6812–6822 (2006).
   PubMed Web of Science ®Google Scholar
• Szucs T. The socio-economic burden of influenza. J. Antimicrob. Chemother.44, 11–15 (1999).
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine25, 5086–5096 (2007).
   PubMed Web of Science ®Google Scholar
• Stinchfield PK. Practice-proven interventions to increase vaccination rates and broaden the immunization season. Am. J. Med.121, S11–S21 (2008).
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K et al. Centers for disease control and prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on immunization practices (ACIP). MMWR Recomm. Rep.6, 59(RR-8), 1–62 (2010).
   Google Scholar
• Muller D, Szucs TD. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection35, 308–319 (2007).
   PubMedGoogle Scholar
• Hollmeyer HG, Hayden F, Poland G, Buchholz U. Influenza vaccination of health care workers in hospitals – a review of studies on attitudes and predictors. Vaccine27, 3935–3944 (2009).
   PubMed Web of Science ®Google Scholar
• Keeton VF, Chen AK. Immunization updates and challenges. Curr. Opin. Pediatr.22, 234–240 (2010).
   PubMedGoogle Scholar
• Evison J, Farese S, Seitz M et al. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin. Infect. Dis.48(10), 1402–1412 (2009).
   PubMed Web of Science ®Google Scholar
• de Bruijn IA, Nauta J, Gerez L et al. The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects. Vaccine24(44–46), 6629–6631 (2006).
   PubMed Web of Science ®Google Scholar
• Baldo V, Menegon T, Bonello C et al. Comparison of three different influenza vaccines in institutionalised elderly. Vaccine19(25–26), 3472–3475 (2001).
   PubMed Web of Science ®Google Scholar
• Pregliasco F, Mensi C, Serpilli W et al. Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly. Aging13(1), 38–43 (2001).
   PubMedGoogle Scholar
• Weller TH, Cheever FS, Enders JF. Immunologic reactions following intradermal inoculation of influenza A and B vaccine. Proc. Soc. Exp. Biol. Med.67, 96–101 (1948).
   PubMed Web of Science ®Google Scholar
• Lenz A, Heine M, Schuler G, Romani N. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest.92, 2587–2596 (1993).
   PubMed Web of Science ®Google Scholar
• Nestle FO, Zheng XG, Thompson CB, Turka LA, Nickoloff BJ. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol.151(11), 6535–6545 (1993). Erratum in: J. Immunol.152(1), 376 (1994).
   PubMed Web of Science ®Google Scholar
• Spellberg B. The cutaneous citadel. A holistic view of skin and immunity. Life Sci.67, 477–502 (2000).
   PubMed Web of Science ®Google Scholar
• Briggs DJ, Banzhoff A, Nicola U et al. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embrio cell vaccine or purified verocell rabies vaccine. Bull. World Health Organ.78, 693–698 (2000).
   PubMed Web of Science ®Google Scholar
• Bryan JP, Sjogren MH, Perine PL, Legters LJ. Low-dose intradermal and intramuscolar vaccination against hepatitis B. Clin. Infect. Dis.14, 697–707 (1992).
   PubMed Web of Science ®Google Scholar
• Redfield RR, Innis BL, Scott RM, Cannon HG, Bancroft WH. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. JAMA254(22), 3203–3206 (1985).
   PubMed Web of Science ®Google Scholar
• Nicolas JF, Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev. Vaccines7, 1201–1214 (2008).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Cannon J et al. Serum antibody responses after intradermal vaccination against influenza. N. Engl. J. Med.351, 2286–2294 (2004).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Newman FK, Wilkins K, Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine25, 6755–6763 (2007).
   PubMed Web of Science ®Google Scholar
• Burland WL. Measles vaccination by the intradermal route. Postgrad. Med. J.45(523), 323–326 (1969).
   PubMedGoogle Scholar
• Zoulek G, Roggendorf M, Deinhardt F, Kunz C. Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus. J. Med. Virol.19(1), 55–61 (1986).
   PubMed Web of Science ®Google Scholar
• Roukens AH, Vossen AC, Bredenbeek PJ, van Dissel JT, Visser LG. Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS One3(4), e1993 (2008).
   PubMed Web of Science ®Google Scholar
• Nelson R. Influenza vaccine shortage hits the USA. Lancet362, 2075 (2004).
   Web of Science ®Google Scholar
• Partridge J, Kieny MP. World Health Organization H1N1 influenza vaccine task force. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009–2010 and comparison with previous estimates and global action plan targets. Vaccine28(30), 4709–4712 (2010).
   PubMed Web of Science ®Google Scholar
• Hessel L. European vaccine manufacturers (EVM) influenza working group. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. Influenza Other Respi. Virus3(4), 165–170 (2009).
   PubMed Web of Science ®Google Scholar
• Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine26, 3197–3208 (2008).
   PubMed Web of Science ®Google Scholar
• Leroux-Roels I, Vets E, Freese R et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomized controlled safety and immunogenicity trial in adults. Vaccine26, 6614–6619 (2008).
   PubMed Web of Science ®Google Scholar
• Beran J, Ambrozaitis A, Laiskonis A et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med.7, 13 (2009).
   PubMed Web of Science ®Google Scholar
• Arnou R, Eavis P, De Juanes Oardo et al. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18–60 years. Hum. Vaccin.6, 346–354 (2010).
   PubMed Web of Science ®Google Scholar
• Frenck RW Jr, Belshe R, Brady RC et al. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine5, 29(34), 5666–5674 (2011).
   Google Scholar
• Holland D, Booy R, De Looze F et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J. Infect. Dis.198, 650–658 (2008).
   PubMed Web of Science ®Google Scholar
• Arnou R, Icardi G, De Decker M et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter Phase 3 study. Vaccine27, 7304–7312 (2009).
   PubMed Web of Science ®Google Scholar
• Van Damme P, Arnou R, Kafeja F et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. BMC Infect. Dis.10, 134 (2010).
   PubMed Web of Science ®Google Scholar
• Morelon E, Noble CP, Daoud S et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Vaccine28(42), 6885–6890 (2010).
   PubMed Web of Science ®Google Scholar
• Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine27(3), 454–459 (2009).
   PubMed Web of Science ®Google Scholar
• Reygrobellet C, Viala-Danten M, Meunier J, Weber F, Nguyen VH. Perception and acceptance of intradermal influenza vaccination: patient reported outcomes from Phase 3 clinical trials. Hum. Vaccin.6(4), 336–345 (2010).
   PubMed Web of Science ®Google Scholar
• Eizenberg P, Booy R, Naser N, Mason G, Stamboulian D, Weber F. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina. Adv. Ther.28(8), 640–649 (2011).
   PubMed Web of Science ®Google Scholar
• Beguin C, Boland B, Ninane J. Health care workers: vectors of influenza virus? Low vaccination rate among hospital health care workers. Am. J. Med. Qual.13, 223–227 (1998).
   PubMedGoogle Scholar